The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Circulating tumor DNA (ctDNA) as a marker of recurrence risk in stage II colon cancer (CC).
Jeanne Tie
No relevant relationships to disclose
Isaac Kinde
No relevant relationships to disclose
Yuxuan Wang
No relevant relationships to disclose
Hui-li Wong
No relevant relationships to disclose
Iain Skinner
No relevant relationships to disclose
Rachel Wong
No relevant relationships to disclose
Malcolm Steel
No relevant relationships to disclose
Luis A. Diaz
No relevant relationships to disclose
Nickolas Papadopoulos
No relevant relationships to disclose
Suzanne Kosmider
No relevant relationships to disclose
Desmond Yip
No relevant relationships to disclose
Craig Underhill
No relevant relationships to disclose
Andrew Mark Haydon
No relevant relationships to disclose
Michael Christie
No relevant relationships to disclose
Robert Strausberg
No relevant relationships to disclose
Kenneth W. Kinzler
No relevant relationships to disclose
Bert Vogelstein
No relevant relationships to disclose
Peter Gibbs
No relevant relationships to disclose